Previous Close | 6.44 |
Open | 6.44 |
Bid | 6.44 x 1000 |
Ask | 6.61 x 3100 |
Day's Range | 6.44 - 6.59 |
52 Week Range | 3.04 - 7.89 |
Volume | |
Avg. Volume | 74,626 |
Market Cap | 81.832M |
Beta (5Y Monthly) | 0.85 |
PE Ratio (TTM) | 33.90 |
EPS (TTM) | 0.19 |
Earnings Date | Oct 31, 2023 - Nov 06, 2023 |
Forward Dividend & Yield | 0.14 (2.15%) |
Ex-Dividend Date | Sep 07, 2023 |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for LFVN
By Karen E. Roman LifeVantage Corporation (Nasdaq: LFVN), a health and wellness company which is currently at loggerheads with The Radoff-Sudbury Group, on Monday filed a shareholder letter urging investors to support its slate of directors at the upcoming annual meeting on Nov. 6. The highlights of LifeVantage’s letter are: Adjusted EBITDA increased 179% to […] The post LifeVantage Issues Letter to Shareholders Urging Support of Its Directors Ahead of Nov. 6 Vote appeared first on CorpGov.
NEW YORK, September 26, 2023--Bradley L. Radoff and Sudbury Capital Fund, LP (together with their affiliates, the "Radoff-Sudbury Group" or "we"), who collectively own approximately 12.8% of the outstanding stock of LifeVantage Corporation (Nasdaq: LFVN) ("LifeVantage" or the "Company"), today announced that they have filed a definitive proxy statement with the U.S. Securities and Exchange Commission (the "SEC") in connection with LifeVantage’s fiscal 2024 Annual Meeting of Stockholders (the "An
Share Price Return Since LV360 Announcement Share Price Return Since LV360 Announcement “Best in Class” Corporate Governance “Best in Class” Corporate Governance Reconciliation of GAAP Net Income to Non-GAAP Adjusted EBITDA (Unaudited) Reconciliation of GAAP Net Income to Non-GAAP Adjusted EBITDA (Unaudited) Issues Letter to Stockholders Highlighting the Company’s Transformation and Progress with LV360 Plan Board Comments on the Radoff-Sudbury Group’s Distracting and Costly Campaign to Remove an